The role of inflammation and infection in coronary artery disease: a clinical perspective
- 1 January 2002
- journal article
- Published by Elsevier in ACC Current Journal Review
- Vol. 11 (1) , 32-34
- https://doi.org/10.1016/s1062-1458(01)00531-1
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary EventsNew England Journal of Medicine, 2001
- Relationship of Dental and Oral Pathology to Systemic IllnessJAMA, 2000
- Infections, Inflammation, and the Risk of Coronary Heart DiseaseCirculation, 2000
- Evidence of a chronic systemic cause of instability of atherosclerotic plaquesThe Lancet, 2000
- Infection and AtherosclerosisCirculation, 1999
- Randomized Secondary Prevention Trial of Azithromycin in Patients With Coronary Artery Disease and Serological Evidence for Chlamydia pneumoniae InfectionCirculation, 1999
- Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol LevelsCirculation, 1998
- Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot studyThe Lancet, 1997
- Elevated Chlamydia pneumoniae Antibodies, Cardiovascular Events, and Azithromycin in Male Survivors of Myocardial InfarctionCirculation, 1997
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997